Mitoxantrone (Hospira, Inc.)


Welcome to the PulseAid listing for the Mitoxantrone drug offered from Hospira, Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: Mitoxantrone
SUBSTANCE NAME: MITOXANTRONE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2006-04-11
END MARKETING DATE: 0000-00-00


Mitoxantrone HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMitoxantrone from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/mL)
START MARKETING DATE: 2006-04-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61703-343_2a4e82a5-e240-45d9-8285-292ad234bfb1
PRODUCT NDC: 61703-343
APPLICATION NUMBER: ANDA076871

Other MITOXANTRONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCMitoxantrone
Hospira, Inc.Mitoxantrone
Pfizer Laboratories Div Pfizer Inc.Mitoxantrone Hydrochloride
Teva Parenteral Medicines, Inc.mitoXANTRONE